Thygesons Superficial Punctate Keratitis (TSPK) Treatment and Management
Various treatments have been used to try and treat Thygeson’s SPK; however, many have been unsuccessful. Antibiotics are not successful and are ineffective in treating the condition. In some instances antivirals have been used and have had mixed results resulting in mild improvements with the use of trifluridine. Contrary information also suggests that the use […]
Patient Diagnosis and Management of Thygeson’s Superficial Punctate Keratitis
Thygeson’s Superficial Punctate Keratitis (TSPK) is a chronic eye disease that has remissions and exacerbations for a few years to decades. Patients typically present with whitish-grey, intraepithelial corneal lesions with no or limited conjunctival involvement. While the etiology of the disease remains controversial, it does have a genetic association with HLA-DR3, which is an antigen […]
Topical Therapy in Thygeson’s Superficial Punctate Keratitis
When someone is affected by the severity of Thygeson’s Superficial Punctate Keratitis or in any of its signs, symptoms, or following remission, various therapies are considered depending on the severity of the disease at the time the patient presents to the eye care specialist. Where a patient presents with a mild case, then they may […]
Corticosteroids and Cyclosporine Treatments for Thygeson’s SPK
Studying the opacities or lesions created by Thygeson’s SPK, also known as Thygeson’s Superficial Punctate Keratopathy, Thygeson’s Superficial Punctate Keratitis and TSPK, shows a crystalline appearance on the corneal surface that resemble snowflakes. They vary in location and fluctuate in numbers even on a weekly basis during a flare up of the condition affecting the […]